Renius Owen

Quest Diagnostics (United States)

Papers

1

Total Citations

26

H-Index

1

About

Dr. Renius Owen is a clinical molecular microbiologist whose work has been pivotal in advancing pandemic response capabilities through high-throughput genomic surveillance. His primary research focuses on developing and validating next-generation sequencing (NGS) workflows for real-time pathogen tracking, with a particular emphasis on SARS-CoV-2. Owen’s landmark study, "Development and validation of a high throughput SARS-CoV-2 whole genome sequencing workflow in a clinical laboratory" (2022, 26 citations), established a robust, scalable protocol for monitoring viral mutations directly in clinical settings. This contribution proved essential for identifying diagnostic and therapeutic targets, enabling more effective COVID-19 control strategies. By streamlining WGS processes, Owen’s work empowered laboratories to rapidly detect emerging variants, providing critical insights for public health interventions. His efforts underscore the vital role of clinical genomics in infectious disease management, bridging the gap between cutting-edge technology and practical, actionable surveillance. Dr. Owen’s research continues to shape how clinical labs prepare for and respond to viral threats, making him a key figure in modern molecular epidemiology.

Research Focus

Key Achievements

1
H-Index
1
Papers
26
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
Development and validation of a high throughput SARS-CoV-2 whole genome sequencing workflow in a clinical laboratory
26 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Quest Diagnostics (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago